Buprenorphine for Opioid Use Disorder: a gold standard treatment that any DEA registered provider can prescribe

Wednesday, January 17 from 7:00 - 8:00 pm CT
Presented by: Aaron Newcomb, D.O., Shawnee Health Care Carbondale, ABPM – Addiction Medicine Subspecialty, IAFP Board Member

Free for IAFP Members; $50 for Non-Members

Learning Objectives:

- Identify opioid addiction as a neurobiological disease process and not a matter of simple moral failure
- Recognize that buprenorphine treatment is a well-established, standard of care for Opioid Use Disorder and any provider with DEA registration can prescribe it
- Recognize how stigma, often based in unfounded fears of buprenorphine abuse and diversion, undermines treatment access and further perpetuates the opioid epidemic

Click here to register